Standish Fleming insider trades: Ambit Biosciences (AMBI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Standish reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 21, 2013 | AMBI | ↑ Buy | 263,301 | $8.00 | $2.1M | Indirect | May 21, 2013 (0d) |
| Dec 22, 2008 | FVRL | ↓ Sell | 478,714 | $0.02 | $8K | Direct | Dec 23, 2008 (1d) |
| Mar 7, 2006 | FVRL | ↑ Buy | 1,140,684 | $5.26 | $6.0M | Direct | Apr 21, 2006 (45d) |
| Feb 15, 2006 | ACOR | ↑ Buy | 125,000 | $6.00 | $750K | Indirect | Feb 17, 2006 (2d) |
| Feb 7, 2005 | FVRL | ↑ Buy | 714,285 | $7.00 | $5.0M | Indirect | Apr 21, 2006 (438d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Standish Fleming's insider trades
Standish Fleming is a director at Ambit Biosciences (AMBI). Since Feb 7, 2005, Standish has reported 4 open-market purchases worth $13.9M and 1 sale worth $8K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include conversions (3 filings), grants and awards (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMBI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.